Please Wait
Applying Filters...

U.S. Patents

Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GENZYME

02 23GENZYME CORP

03 7KADMON PHARMS LLC

04 27SANOFI AVENTIS US

05 569ABBVIE

06 4ABBVIE ENDOCRINE INC

07 21ALLERGAN

08 703PHARMACYCLICS LLC

09 20ATHENA

10 6DR REDDYS

11 2MISSION PHARMACAL

12 18AUCTA

13 1DOUGLAS PHARMS

14 21STRIDES PHARMA INTL

15 9LUNDBECK PHARMS LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2034-02-04

TERIFLUNOMIDE

US Patent Number : 9186346

Drug Substance Claim :

Drug Product Claim :

Application Number : 202992

Patent Use Code : U-1786

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2034-02-04

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2027-03-12

TERIFLUNOMIDE

US Patent Number : 6794410*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 202992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-12

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2028-08-08

VANDETANIB

US Patent Number : 8067427

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22405

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-08

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-10-07

BELUMOSUDIL MESYLATE

US Patent Number : 10696660

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-3246

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-07

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2030-09-14

TERIFLUNOMIDE

US Patent Number : 8802735

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202992

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-09-14

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-03-22

FITUSIRAN SODIUM

US Patent Number : 9127274

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219019

Patent Use Code : U-4165

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-22

Sanofi Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2029-04-16

DRONEDARONE HYDROCHLORIDE

US Patent Number : 8410167

Drug Substance Claim :

Drug Product Claim :

Application Number : 22425

Patent Use Code : U-1388

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2029-04-16

Sanofi Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2040-10-13

RILZABRUTINIB

US Patent Number : 12178818

Drug Substance Claim :

Drug Product Claim :

Application Number : 219685

Patent Use Code : U-4267

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-10-13

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-09-06

RILZABRUTINIB

US Patent Number : 8940744

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219685

Patent Use Code : U-4270

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-06

Sanofi Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2033-10-07

BELUMOSUDIL MESYLATE

US Patent Number : 10696660

Drug Substance Claim :

Drug Product Claim :

Application Number : 214783

Patent Use Code : U-4260

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-07

Sanofi Company Banner